The Psychedelics Policy Newsletter examines the latest psychedelics policy news and developments.
If you would like to receive the Psychedelics Policy Newsletter via email, please enter your email address below.
Previous issues of this newsletter are below and Reason Foundation's drug-related research is available here.
Sign up for the Psychedelics Policy Newsletter
Plus: State regulation progress and more.
Plus: A policy brief on psychedelics and neurodegenerative treatments, alternatives to 'double-blind' trials, and more.
Plus: Government funding for addiction research, veteran’s administration pursues psychedelics, and more.
Plus: A profile of ibogaine advocate Bryan Hubbard, the Drug Enforcement Administration head worries about ketamine, and more.
Plus: Food and Drug Administration approval of MDMA is tentative, the psychedelic origins of Whole Foods, and more.
Plus: The National Institute of Health awards money for addiction research, a Michigan poll signals interest in psychedelics, and more.
A model that would reduce costs and increase consumer access to psychedelics by streamlining the overall regulatory burden.
Plus: State news roundup and the defense spending bill calls for research on using psychedelics to treat PTSD in military members, and more.
Plus: New Drug Policy Handbook, the latest on implementing Colorado's legalization, and more.